Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel use of radiotracer reveals extent of mycoardial infarction damage

17.06.2002


Investigators reporting at the 49th Annual Meeting of the Society of Nuclear Medicine (SNM) have determined that a noninvasive nuclear medicine technique can accurately and safely detect the extent of persistent heart muscle damage after a heart attack. In two studies, researchers reported on the safety and efficacy 201Tl/99mTc Annexin (ApomateTM) SPECT in detecting and localizing myocardial tissue damage and revealing areas of persistent cellular injury. SPECT (single-photon emission computed tomography) is a nuclear medicine procedure that uses the injection of a radiotracer to produce three-dimensional computer-reconstructed images that reveal information about both structure and function.



In one study, Neil Steinmetz, MD, and colleagues from eight medical centers in the U.S. and Canada reported on the use of 201Tl/99mTc Annexin SPECT in 59 patients who had experienced a myocardial infarction (MI) within the previous 96 hours. 81% of these patients showed persistent myocardial tissue injury on imaging. Even in patients who had been successfully revascularized (blood flowing normally to the heart), the 201Tl/99mTc Annexin SPECT revealed areas of persistent cellular damage. In a second study, Raymond Taillefer, MD, and colleagues from the Centre Hospitalier de l’Université de Montréal (Canada), provided additional evidence that this imaging procedure is effective during the first 4 days after an MI.

Apomate (Theseus Imaging, Boston, MA) is a radiopharmaceutical originally developed for imaging cell death (apoptosis and necrosis) as an early indicator of response to anticancer treatment. The studies reported at the SNM meeting are part of a larger effort to use Apomate and nuclear medicine techniques to determine the extent and location of myocardial cellular injury after an infarction and the response to treatment. Evidence presented at the SNM meeting suggests that Annexin SPECT is safe and effective in detecting persistent areas of damage and diagnosing the extent of past myocardial injury in patients who have experienced MIs. Using this information, physicians may be able to tailor treatment plans and lifestyle changes to the specific needs of each patient Myocardial infarction is the medical term for a heart attack and results when the supply of oxygen is cut off to some portion of the heart muscle. The American Heart Association estimates that more than a million Americans will experience a heart attack in 2002, and more than 300,000 American will die of sudden cardiac arrest.




The Society of Nuclear Medicine Annual Meeting is being held June 15–19 at the Los Angeles Convention Center, Los Angeles, CA. In addition to educational sessions, the meeting will focus on leading medical developments in the field of nuclear medicine, including radioimmunotherapy with a new class of drugs that target cancer, diagnostic breakthroughs with PET, and other topics. More than 5,000 specialists in the field of nuclear medicine, including scientists, technologists, researchers, and representatives from the medical industry, are expected to attend. The Society of Nuclear Medicine is an international scientific and professional organization with more than 13,000 members dedicated to promoting the science, technology, and practical applications of nuclear medicine. The SNM is based in Reston, VA.

For late-breaking news about the world of nuclear medicine and events at the 49th Annual Society of Nuclear Medicine meeting, visit www.snm.org

Abstract 11. Sunday, June 16, 3:06–3:18 p.m. Room 410
Simultaneous Dual Isotope 201Tl/99mTc-Annexin (ApomateTM) SPECT in Detection of Acute Myocardial Infarction: Initial Results of a Phase II Multicenter
N. Steinmetz, R. Taillefer, R. C. Hendel, F. L. Weiland, D.S. Berman, M.I. Travin, M. Fish, M.E. Mallett, and A.M. Green Main contact:
Neil Steinmetz MD

Abstract 15. Sunday, June 16, 4:15–4:27 p.m. Room 410
99mTc-Annexin V Scintigraphy in Detection of Acute Myocardial Infarction (MI): Repeat Imaging After the Onset of Acute Symptoms in Order to Evaluate the Persistence of Abnormal Radiotracer Uptake
R. Taillefer, D.C. Phaneuf, D.H. Duong, C. Benjamin, S. Lajeunesse, A. Gagnon, A.M. Green, N.D. Steinmetz
Contact author: R. Taillefer
Centre Hospitalier de l’Université de Montréal
Montréal, PQ, Canada

Email: micheline.lauzon.chum@ssss.gouv.qc.ca

Karen Lubieniecki | EurekAlert

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>